INCB160058
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for INCB160058, covering 2025-10-14 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms [Phase 1]